Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammation: Introduction01:28

Inflammation: Introduction

Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional Peroxidase-Mimicking Ag<sub>2</sub>S/NiS/Reduced Graphene Oxide Nanozyme for Hydrogen Peroxide Determination and Dye Degradation.

ChemPlusChem·2026
Same author

Comparative Study of Hyperbaric Bupivacaine Versus Levobupivacaine for Rapid Sequence Spinal Anesthesia in Category 1 and 2 Cesarean Sections.

Cureus·2026
Same author

Robotic surgery: The beginning and the journey so far.

The National medical journal of India·2026
Same author

Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent Cancers.

Journal of medicinal chemistry·2026
Same author

International Delphi consensus on single-port robotic radical prostatectomy: patient selection, surgical technique, and training.

BJU international·2026
Same author

New CPT codes for prostate biopsy improve alignment of reimbursement with evidence-based practice.

Urologic oncology·2026

Related Experiment Video

Updated: May 30, 2026

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

Role of inflammation in bladder function and interstitial cystitis.

Sonal Grover1, Abhishek Srivastava, Richard Lee

  • 1James Buchanan Brady Foundation Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, USA.

Therapeutic Advances in Urology
|July 27, 2011
PubMed
Summary

Interstitial cystitis (IC) is a chronic bladder inflammation causing pain and irritative symptoms. Current treatments focus on multimodal therapies to manage inflammation, with surgery reserved for severe, irreversible cases.

Keywords:
bladderinflammationinterstitial cystitismanagementpainful bladder syndrome

More Related Videos

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

Area of Science:

  • Urology
  • Immunology
  • Pathophysiology

Background:

  • Cystitis, or bladder inflammation, significantly impacts bladder function.
  • Interstitial cystitis (IC) is a chronic condition defined by bladder pain and irritative symptoms lasting over six months.
  • IC is often diagnosed in women and is considered a diagnosis of exclusion, with potential contributing factors including infection, autoimmunity, and genetic predisposition.

Purpose of the Study:

  • To confirm the central role of inflammation in the pathogenesis of interstitial cystitis.
  • To outline current management strategies for interstitial cystitis.
  • To identify indications for surgical intervention in refractory cases.

Main Methods:

  • Review of existing literature on cystitis and interstitial cystitis.
  • Analysis of proposed etiological factors for interstitial cystitis.
  • Description of multimodal therapeutic approaches and surgical options.

Main Results:

  • Inflammation plays a confirmed central role in the development of interstitial cystitis.
  • Multimodal therapy is the standard approach to manage the inflammatory cycle in IC patients.
  • Surgical management is reserved for patients with irreversible pathologies like fibrosis.

Conclusions:

  • Inflammation is key to interstitial cystitis pathogenesis.
  • Comprehensive, multimodal treatment is essential for managing IC.
  • Surgery is a last resort for advanced, refractory interstitial cystitis with fibrosis.